VIDEO: RevitalVision CEO talks US launch of digital vision enhancement technology
ORLANDO — In this Healio Video Perspective from Vision Expo East, Yair Yahav, CEO and founder of RevitalVision, discusses the U.S. launch of the company’s neurological therapy indicated to improve vision outcomes across various conditions.
According to Yahav, the prescribed, home-based vision training software is the only FDA-cleared product for the treatment of amblyopia among patients aged 9 years and older.
“RevitalVision offers eye care specialists a unique tool to improve vision beyond current practice by treating the brain visual cortex in addition to the eyes,” he said.